IL1B and hydrops fetalis: Interleukin 6 (IL6) and 1b (IL-1b) showed an increasing tendency already in the very early phase of HF development (week +2) and were significantly elevated five weeks after termination of DOXO treatment compared to untreated counterparts (Fig. 10A, B).